APRE Competitors & Alternatives
Compare Aprea Therapeutics Inc with similar stocks in the same industry
Biotechnology
APRE
Main Stock$0.76
Tradestie Score
49
Market Cap
$8.50M
Revenue Growth
-1.0%
Analyst Upside
+464.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$13.74
|
$170.45M | - | 53 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$4.92
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.44
|
$133.50M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$18.85
|
$110.20M | - | 48 | Compare |
|
BYSI
BeyondSpring Inc. Ordinary Shares
|
$1.74
|
$72.18M | - | 55 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.33
|
$71.69M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.44
|
$67.94M | - | 59 | Compare |
|
CYCN
Cyclerion Therapeutics, Inc. Common Stock
|
$3.00
|
$7.59M | - | 48 | Compare |
|
GRTX
GRTX
|
- | - | - | - | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More APRE Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry